The effect of oral immunization on corneal allograft survival

Transplantation

Volumn 61, Issue 6, 1996, Pages 920-926

  He, Yu Guang ^a   Mellon, Jessamee ^a   Niederkorn, Jerry Y ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CORNEA TRANSPLANTATION; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ANIMALS; CORNEA; CORNEAL TRANSPLANTATION; EPITHELIUM; EPITOPES; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HYPERSENSITIVITY, DELAYED; IMMUNIZATION; IMMUNOSUPPRESSION; INCIDENCE; ISOANTIBODIES; ISOANTIGENS; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MICE, INBRED C3H; MICE, INBRED NZB; T-LYMPHOCYTES, CYTOTOXIC; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0029887724     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199603270-00014     Document Type: Article

References (32)

1. Shapiro MB, Mandel MR, Krachmer JH. Adult penetrating keratoplasty. In: Brightbill FL, ed. Rejection in corneal surgery theory, technique and tissue. St. Louis: Mosby, 198: 310.
2. Lindstrom RL. Advances in corneal transplantation. N Engl J Med 1986; 315: 1.
3. Belin MW, Bouchard CS, Phillips TM. Update on topical cyclosporin A: background, immunology and pharmacology. Cornea 1990; 9: 184.
4. Dupon E, Wybran J, Tonssaint C. Glucocorticosteroids and organ transplantation. Transplantation 1984; 37: 331.
5. Friedman A, Al-Sabbagh A, Santos LMB, et al. Oral tolerance: a biologically relevant pathway to generate peripheral tolerance against external and self antigens. In: Granstein RD, ed. Mechanisms of immune regulation. Basel: Karger, 1994: 259.
6. Higgins PJ, Weiner HL. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J Immunol 1988; 140: 440.
7. Nussenblatt RB, Caspi RR, Mahdi R, et al. Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. J Immunol 1989; 144: 1689.
8. Zhang Z, Lee C, Weiner H. Suppression of adjuvant arthritis by oral administration of type II collagen. J Immunol 1980; 145: 2489.
9. Zhang Z, Davidson L, Elisenbarth G, Weiner H. Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc Natl Acad Sci USA 1991; 88: 10252.
10. Weiner HL, Mackin GA, Matsui M, et al. Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science 1993; 259: 1321.
11. Trentham DE, Dynesius-Trentham RA, Orav EJ, et al. Effects of oral administration of type II collagen on rheumatoid arthritis. Science 1993; 261: 1727.
12. Sayegh MH, Khoury SJ, Hancock WW, Weiner HL, Carpenter CB. Induction of immunity and oral tolerance with polymorphic class II major histocompatibility complex allopeptides in the rat. Proc Nat Acad Sci USA 1992; 89: 7762.
13. Sayegh MH, Zhang ZJ, Hancock WW, Kwok CA, Carpenter CB, Weiner HL. Orally administered alloantigen down-regulates the immune response to histocompatibility antigens and prevents sensitization by skin allografts. Transplantation 1992; 53: 163.
14. Hancock WW, Khoury SJ, Carpenter CB, Sayegh MH. Differential effects of oral versus intrathymic administration of polymorphic MHC class II peptides on mononuclear and endothelial cell activation and cytokine expression during a delayed-type hypersensitivity response. Am J Pathol 1994; 144: 1149.
15. Hancock WW, Sayegh MH, Kwok CA, Weiner HL, Carpenter CB. Oral, but not intravenous alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation. Transplantation 1993; 55: 1112.
16. He YG, McCulley JP. Growing human corneal epithelium on collagen shield and subsequent transfer to denuded cornea in vitro. Curr Eye Res 1991; 10: 851.
17. Yue BYJT, Sugar J, Gilboy JE, Elvart JL. Growth of human corneal endothelial cells in culture. Invest Ophthalmol Vis Sci 1989; 30: 248.
18. Wilson SE, Weng J, Blair S, He Y-G, Lloyd S. Expression of E6/E7 or SV40 large T antigen-coding oncogenes in human corneal endothelial cells indicates regulated high-proliferative capacity. Invest Ophthalmol Vis Sci 1995; 36: 32.
19. She SC, Steahly LP, Moticka EJ. A method for performing full-thickness, orthotopic, penetrating keratoplasty in the mouse. Ophthalm Surg 1990; 21: 781.
20. He YG, Ross J, Niederkorn JY. Promotion of murine orthotopic corneal allograft survival by systemic administration of anti CD4 monoclonal antibody. Invest Ophthalmol Vis Sci 1991; 32: 2723.
21. + Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens. J Immunol 1986; 136: 4362.
22. Niederkorn JY, Peeler JS, Mellon J. Phagocytosis of particulate antigens by corneal epithelial cells stimulates interleukin-1 secretion and migration of Langerhans cells into central cornea. Regional Immunol 1989; 2: 83.
23. Streilein JW, McCulley JP, Niederkorn JY. Heterotopic corneal grafting in mice: a new approached to the study of corneal alloimmunity. Invest Ophthalmol Vis Sci 1982; 23: 489.
24. Peeler J, Matoba AY, Niederkorn JY. Corneal allografts induce cytotoxic T cell but not delayed hypersensitivity responses in mice. Invest Ophthalmol Vis Sci 1985; 26: 1516.
25. Sonoda Y, Streilein JW. Impaired cell-mediatd immunity in mice bearing healthy orthotopic corneal allografts. J Immunol 1993; 150: 1727.
26. Katami M, White DJG, Watson PG. An analysis of corneal graft rejection in the rat. Transplant Proc 1989; 21: 3147.
27. Niederkorn JY. Effect of cytokine-induced migration of Langerhans cells on corneal allograft survival. Eye 1995; 9: 215.
28. Ross J, He Y-G, Pidherney M, Mellon J, Niederkorn JY. The differential effects of donor versus host Langerhans cells in the rejection of MHC-matched corneal allografts. Transplantation 1991; 52: 857.
29. The Collaborative Corneal Transplantation Studies Research Group. The collaborative corneal transplantation studies (CCTS): effectiveness of histocompatibility matching in high-risk corneal transplantation. Arch Ophthalmol 1992; 110: 1392.
30. Feder JM, Antonysamy MA, Moticka EJ. Oral administration of alloantigens enhances corneal allograft survival. Invest Ophthalmol Vis Sci (suppl) 1995; 36: S1010.
31. Tevethia SS. Recognition of simian virus 40 T antigen by cytotoxic T lymphocytes. Mol Biol Med 1990; 7: 83.
32. Chen Y, Inobe J-I, Marks R, Gonnella P, Kuchroo VK, Weiner HL. Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 1995; 376: 177.